» Articles » PMID: 23377827

Excess Glucose Induces Hypoxia-inducible Factor-1α in Pancreatic Cancer Cells and Stimulates Glucose Metabolism and Cell Migration

Overview
Specialties Oncology
Pharmacology
Date 2013 Feb 5
PMID 23377827
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer patients frequently show hyperglycemia, but it is uncertain whether hyperglycemia stimulates pancreatic cancer cells. We have investigated whether excess glucose induces hypoxia-inducible factor-1α (HIF-1α) and stimulates glucose metabolism and cell migration in pancreatic cancer cells. We studied wild-type (wt) MiaPaCa2 pancreatic cancer cells and a MiaPaCa2 subline (namely si-MiaPaCa2) that had HIF-1α-specific small interfering RNA. Wt-MiaPaCa2 cells are known to be HIF-1α-positive in hypoxia and HIF-1α-negative in normoxia, whereas si-MiaPaCa2 cells are devoid of HIF-1α in both normoxia and hypoxia. We incubated these cells with different amounts of glucose and determined HIF-1α mRNA and protein by real-time polymerase chain reaction and western blotting. We determined glucose consumption, lactate production and intracellular hexokinase-II and ATP to assess glucose metabolisms and determined pyruvate dehydrogenase kinase-1, reactive oxygen species and fumarate to assess mitochondrial activities. Further, we studied cell migration using a Boyden chamber. Excess glucose (16.7-22.2mM) increased HIF-1α in hypoxic wt-MiaPaCa2 cells. HIF-1α expression increased ATP contents and inhibited mitochondrial activities. Extracellular glucose and hypoxia stimulated glucose metabolisms independent of HIF-1α. Excess glucose stimulated the migration of wt- and si-MiaPaCa2 cells in both normoxia and hypoxia. Thus, glucose stimulated cell migration independent of HIF-1α. Nevertheless, hypoxic wt-MiaPaCa2 cells showed greater migrating ability than their si-MiaPaCa2 counterparts. We conclude that (1) excess glucose increases HIF-1α and ATP in hypoxic wt-MiaPaCa2 cells, (2) extracellular glucose and hypoxia regulate glucose metabolisms independent of HIF-1α and (3) glucose stimulates cell migration by mechanisms that are both dependent on HIF-1α and independent of it.

Citing Articles

Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms.

Zhang Y, Li Y, Xue C, Li S, Gao Z, Qin K Front Endocrinol (Lausanne). 2024; 15:1396022.

PMID: 39290325 PMC: 11405243. DOI: 10.3389/fendo.2024.1396022.


Gene Expression of Glycolysis Enzymes in MCF-7 Breast Cancer Cells Exposed to Warburg Effect and Hypoxia.

Bayar I, Ekren Asici G, Bildik A, Kiral F Int J Mol Cell Med. 2024; 13(1):29-45.

PMID: 39156867 PMC: 11329934. DOI: 10.22088/IJMCM.BUMS.13.1.29.


Functional Consequences of Shifting Transcript Boundaries in Glucose Starvation.

Nguyen L, Mori M, Yasuda Y, Galipon J Mol Cell Biol. 2023; 43(11):611-628.

PMID: 37937348 PMC: 10761120. DOI: 10.1080/10985549.2023.2270406.


Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma.

Rana P, Goparaju K, Driscoll J Front Oncol. 2023; 13:1141851.

PMID: 37361580 PMC: 10285382. DOI: 10.3389/fonc.2023.1141851.


HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.

Huang Y, Chen Y, Huang C, Kuo S, Liao Y, Jhang W Cancers (Basel). 2022; 14(16).

PMID: 36011045 PMC: 9406860. DOI: 10.3390/cancers14164053.


References
1.
Fan Y, Dickman K, Zong W . Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem. 2009; 285(10):7324-33. PMC: 2844180. DOI: 10.1074/jbc.M109.035584. View

2.
Zhong H, De Marzo A, Laughner E, Lim M, Hilton D, Zagzag D . Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999; 59(22):5830-5. View

3.
Koivunen P, Hirsila M, Remes A, Hassinen I, Kivirikko K, Myllyharju J . Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2006; 282(7):4524-4532. DOI: 10.1074/jbc.M610415200. View

4.
Da Silva A, El-Bacha T, Kyaw N, Dos Santos R, da-Silva W, Almeida F . Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J. 2008; 417(3):717-26. DOI: 10.1042/BJ20080805. View

5.
Iqbal M, Bamezai R . Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin. PLoS One. 2012; 7(5):e36764. PMC: 3344940. DOI: 10.1371/journal.pone.0036764. View